Zivo Bioscience- Warrants (29/04/2026) (ZIVOW) has a profit margin of -8388.36%, below the Consumer Discretionary sector average of 10.25%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Zivo Bioscience- Warrants (29/04/2026)'s profit margin stands at -8388.36% as of June 2026. That compares with -5558.26% in the prior-year period — down 50.9% year over year. That is below the Consumer Discretionary sector average of 10.25%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Zivo Bioscience- Warrants (29/04/2026) reported -8388.36% in profit margin versus -5558.26% a year earlier — a 50.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
Zivo Bioscience- Warrants (29/04/2026) sits lower the Consumer Discretionary benchmark (10.25%) with a profit margin of -8388.36%. That is roughly 81921.3% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of -8388.36% for Zivo Bioscience- Warrants (29/04/2026) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Zivo Bioscience- Warrants (29/04/2026)'s profit margin evolved across reporting periods, while the comparison chart places ZIVOW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.